Myelitis disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: MYL001 MIFTS: 51	Myelitis Categories: Rare diseases, Neuronal diseases
Genes Tissues Related diseases Publications Pathways Drugs Download Expand all tables

Sources

Aliases & Classifications for Myelitis

MalaCards integrated aliases for Myelitis:

Name: Myelitis ¹² ⁷⁶ ⁵³ ⁵⁵ ⁴⁴ ¹⁵ ⁷³

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Neuronal diseases

See all MalaCards categories (disease lists)

External Ids:

Disease Ontology ¹² DOID:322

MeSH ⁴⁴ D009187

NCIt ⁵⁰ C26832

SNOMED-CT ⁶⁸ 192682002 267682000 41370002

UMLS ⁷³ C0026975

Sources

Summaries for Myelitis

Disease Ontology : ¹² A spinal cord disease that is characterized by inflammation of the white matter or gray matter of the spinal cord.

MalaCards based summary : Myelitis is related to acute transverse myelitis and transverse myelitis. An important gene associated with Myelitis is AQP4 (Aquaporin 4), and among its related pathways/superpathways are TGF-Beta Pathway and Akt Signaling. The drugs Mycophenolate mofetil and Mycophenolic acid have been mentioned in the context of this disorder. Affiliated tissues include spinal cord, brain and lung, and related phenotypes are hematopoietic system and immune system

Wikipedia : ⁷⁶ Myelitis is inflammation of the spinal cord which can disrupt the normal responses from the brain to the... more...

Sources

Related Diseases for Myelitis

Diseases related to Myelitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 345)

#	Related Disease	Score	Top Affiliating Genes
1	acute transverse myelitis	34.5	AQP4 IL6
2	transverse myelitis	31.2	APOH AQP4 IL17A IL6 MBP TNF
3	systemic lupus erythematosus	30.6	APOH HLA-DPB1 IL17A IL6 TNF
4	arteriovenous fistula	30.5	APOH IL6
5	pneumonia	30.4	CCL11 IL6 TNF
6	acute disseminated encephalomyelitis	30.3	AQP4 MBP MOG
7	laryngitis	30.0	IL6 TNF
8	hematopoietic stem cell transplantation	29.9	IL6 TNF
9	spinal cord injury	29.8	AQP4 IL6 TNF
10	lyme disease	29.8	IL17A IL6 TNF
11	neuromyelitis optica	29.8	AQP4 HLA-DPB1 IL17A IL6 MBP MOG
12	rubella	29.5	HLA-DPB1 MOG TNF
13	colitis	29.5	IL17A IL6 TNF
14	spondylitis	29.5	IL17A IL6 TNF
15	intracranial hypertension	29.4	APOH AQP4 TNF
16	wegener granulomatosis	29.4	HLA-DPB1 IL6 TNF
17	cytomegalovirus infection	29.4	IL6 TNF
18	dermatitis, atopic	29.3	CCL11 IL17A TNF
19	psoriatic arthritis	29.2	IL17A IL6 TNF
20	optic nerve disease	29.1	AQP4 MBP MOG
21	connective tissue disease	29.1	APOH HLA-DPB1 IL6 TNF
22	optic neuritis	28.8	AQP4 MBP MOG TNF
23	neuritis	28.8	AQP4 MBP MOG TNF
24	rheumatoid arthritis	28.8	HLA-DPB1 IL17A IL6 TNF
25	internuclear ophthalmoplegia	28.7	AQP4 MBP MOG
26	viral encephalitis	28.6	IL6 MBP TNF
27	localized scleroderma	28.6	IL6 TNF
28	stroke, ischemic	28.6	APOH AQP4 MBP
29	narcolepsy	28.5	AQP4 HLA-DPB1 MOG TNF
30	malaria	28.1	CCL11 IL17A IL6 IL9 TNF
31	multiple sclerosis	27.5	AQP4 IL17A IL6 MBP MOG TNF
32	demyelinating disease	27.4	AQP4 IL17A MBP MOG TNF
33	acute flaccid myelitis	12.3
34	idiopathic acute transverse myelitis	12.1
35	secondary acute transverse myelitis	12.0
36	radiation myelitis	12.0
37	foix-alajouanine syndrome	11.5
38	antiphospholipid syndrome	11.2
39	thyrotoxic periodic paralysis	10.9
40	lupus - neurological sequelae	10.9
41	paresthesia	10.9
42	papillary conjunctivitis	10.7	CCL11 IL6
43	chronic eosinophilic pneumonia	10.7	CCL11 IL6
44	encephalitis	10.7
45	scorpion envenomation	10.6	IL6 TNF
46	viral pneumonia	10.5	IL17A IL6
47	leukomalacia	10.5	IL6 TNF
48	angioimmunoblastic lymphadenopathy with dysproteinemia	10.5	IL6 TNF
49	critical limb ischemia	10.5	IL6 TNF
50	streptococcal toxic-shock syndrome	10.5	IL6 TNF

Graphical network of the top 20 diseases related to Myelitis:

Sources

Symptoms & Phenotypes for Myelitis

MGI Mouse Phenotypes related to Myelitis:

⁴⁶

#	Description	MGI Source Accession	Score	Top Affiliating Genes
1	hematopoietic system	MP:0005397	9.91	IL9 ITGB3 MBP MOG AQP4 TNF
2	immune system	MP:0005387	9.81	IL9 ITGB3 MBP MOG AQP4 TNF
3	digestive/alimentary	MP:0005381	9.8	IL9 ITGB3 AQP4 TNF IL17A IL6
4	respiratory system	MP:0005388	9.43	ITGB3 AQP4 TNF CCL11 IL17A IL6
5	vision/eye	MP:0005391	9.1	ITGB3 MBP MOG AQP4 TNF IL6

Sources

Drugs & Therapeutics for Myelitis

Drugs for Myelitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 166)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Mycophenolate mofetil

Approved, Investigational

Phase 4

128794-94-5

5281078

Mycophenolic acid

Approved

Phase 4

24280-93-1

446541

Prednisone

Approved, Vet_approved

Phase 4

53-03-2

5865

Mitoxantrone

Approved, Investigational

Phase 4

65271-80-9

4212

Methylprednisolone

Approved, Vet_approved

Phase 4,Phase 3,Phase 1,Phase 2

83-43-2

6741

Prednisolone

Approved, Vet_approved

Phase 4,Phase 3,Phase 1,Phase 2

50-24-8

5755

Interferon beta-1a

Approved, Investigational

Phase 4,Phase 2

145258-61-3

6438354

Neomycin

Approved, Vet_approved

Phase 4

1404-04-2

8378

Phenol

Approved, Experimental

Phase 4

108-95-2

996

Zinc

Approved, Investigational

Phase 4,Not Applicable

7440-66-6

23994

Zinc sulfate

Approved, Investigational

Phase 4,Not Applicable

7733-02-0

Edetic Acid

Approved, Vet_approved

Phase 4,Phase 3,Phase 2

60-00-4, 62-33-9

6049

Iron

Approved

Phase 4,Phase 3,Phase 2

7439-89-6

23925

Pentetic acid

Approved

Phase 4,Phase 3,Phase 2

67-43-6

Antibodies

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

Antibodies, Blocking

Phase 4

Immunoglobulins

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

Vaccines

Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable

Anti-Bacterial Agents

Phase 4

Antibiotics, Antitubercular

Phase 4

Anti-Infective Agents

Phase 4,Phase 2,Phase 3,Early Phase 1

Anti-Inflammatory Agents

Phase 4,Phase 3,Phase 1

Antineoplastic Agents, Hormonal

Phase 4,Phase 3,Phase 1

Antitubercular Agents

Phase 4

glucocorticoids

Phase 4,Phase 3,Phase 1

Hormone Antagonists

Phase 4,Phase 3,Phase 1

Hormones

Phase 4,Phase 3,Phase 1

Hormones, Hormone Substitutes, and Hormone Antagonists

Phase 4,Phase 3,Phase 1

Analgesics

Phase 4

Peripheral Nervous System Agents

Phase 4,Phase 3,Phase 1

Topoisomerase Inhibitors

Phase 4,Phase 1,Phase 2

Antiemetics

Phase 4,Phase 3,Phase 1

Autonomic Agents

Phase 4,Phase 3,Phase 1

Gastrointestinal Agents

Phase 4,Phase 3,Phase 1,Phase 2

Methylprednisolone acetate

Phase 4,Phase 3,Phase 1,Phase 2

Methylprednisolone Hemisuccinate

Phase 4,Phase 3,Phase 1,Phase 2

Neuroprotective Agents

Phase 4,Phase 3,Phase 1

Prednisolone acetate

Phase 4,Phase 3,Phase 1,Phase 2

Prednisolone hemisuccinate

Phase 4,Phase 3,Phase 1,Phase 2

Prednisolone phosphate

Phase 4,Phase 3,Phase 1,Phase 2

Protective Agents

Phase 4,Phase 3,Phase 2,Phase 1

Adjuvants, Immunologic

Phase 4,Phase 1,Phase 2

Antiviral Agents

Phase 4,Phase 2,Phase 3,Early Phase 1

Interferon-beta

Phase 4,Phase 2

interferons

Phase 4,Phase 2

Polymyxin B

Phase 4

Polymyxins

Phase 4

Pharmaceutical Solutions

Phase 4,Phase 3,Phase 2,Phase 1

Heptavalent Pneumococcal Conjugate Vaccine

Phase 4,Phase 3,Phase 2

Micronutrients

Phase 4,Not Applicable

Interventional clinical trials:

(show top 50) (show all 253)

#	Name	Status	NCT ID	Phase	Drugs
1	Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV Vaccine	Unknown status	NCT01841671	Phase 4
2	Mycophenolate Mofetil Treatment With Neuromyelitis Optica Spectrum Disorders in Chinese Patients	Unknown status	NCT02809079	Phase 4	Mycophenolate mofetil;Prednisone
3	Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders	Unknown status	NCT02021825	Phase 4	Mitoxantrone
4	Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis	Completed	NCT00179478	Phase 4	interferon beta 1a 30 ug IM once weekly
5	A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic’s Disease)	Completed	NCT00304291	Phase 4	Mitoxantrone
6	Oral Corticotherapy in Megadoses to Treat Multiple Sclerosis During Relapse	Completed	NCT00753792	Phase 4	methylprednisolone;methylprednisolone;Placebo
7	A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults	Completed	NCT01427309	Phase 4
8	Immunogenicity of Monovalent Type 2 Oral Poliovirus Vaccine	Completed	NCT02643368	Phase 4
9	A Study to Evaluate the Safety and Immunogenicity of Monovalent OPV2 in Children Aged 1 to 5 Years in Lithuania	Completed	NCT02582255	Phase 4
10	A Study to Evaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of Age	Completed	NCT02580201	Phase 4
11	Intestinal and Humoral Immunity of Sequential Polio Vaccination Schedules	Completed	NCT02412514	Phase 4
12	Polio End-game Strategies - Poliovirus Type 2 Challenge Study	Completed	NCT02189811	Phase 4
13	Study of IMOVAX POLIO® Subcutaneous as a Booster Vaccine in Pre-school Age Children in Japan	Completed	NCT02005536	Phase 4
14	IPV Clinical Trial - The Gambia	Completed	NCT01847872	Phase 4	IPV IM Needle;IPV ID Needle;IPV IM Device;IPV ID Device
15	Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV Vaccine	Completed	NCT01831050	Phase 4
16	IPV in Moderate to Severe Chronic Malnourished 9-12 Month Old Children in Karachi.	Completed	NCT01695798	Phase 4
17	Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery	Completed	NCT02422264	Phase 4	Prevnar13
18	Zinc and/or Probiotic Supplementation of Rotavirus and Oral Polio Virus Vaccines	Completed	NCT01616693	Phase 4
19	Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis Vaccine	Completed	NCT01475539	Phase 4
20	A Safety Study of IMOVAX Polio Vaccine in Selected Cities in China	Completed	NCT01278433	Phase 4
21	A Study of the Safety of IMOVAX Polio™ in China	Completed	NCT01244464	Phase 4
22	Study to Evaluate the Safety of Co-administration of GSK Biologicals' Poliorix and Infanrix in Healthy Children in Russia	Completed	NCT01094171	Phase 4
23	Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE	Completed	NCT01546909	Phase 4
24	Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course	Completed	NCT01457547	Phase 4
25	Regulatory Post-Marketing Surveillance Study for TETRAXIM™	Completed	NCT01437423	Phase 4
26	Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™	Completed	NCT01358825	Phase 4
27	Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults	Completed	NCT01323959	Phase 4
28	Immunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of Age	Completed	NCT01031303	Phase 4
29	Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants	Completed	NCT00753649	Phase 4
30	Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine	Completed	NCT00635128	Phase 4
31	Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children	Completed	NCT00611559	Phase 4
32	Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine	Completed	NCT00514059	Phase 4	Boostrix polio
33	Assess the Safety & Reactogenicity of DTPa-IPV/Hib Vaccine Administered at 3, 4, 5 & 18 Mths of Age, in Healthy Infants	Completed	NCT00325156	Phase 4
34	Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis Vaccine	Completed	NCT00304265	Phase 4
35	Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand	Completed	NCT00255021	Phase 4
36	Comparison of Immunity Following IPV Versus fIPV: a Community Based Randomized Controlled Trial in Pakistan	Recruiting	NCT03286803	Phase 4
37	Duration of IPV Priming and Antibody Decay	Recruiting	NCT03202719	Phase 4
38	Fractional Inactivated Poliovirus Vaccine Booster and Rotavirus Study	Active, not recruiting	NCT02847026	Phase 4
39	MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study	Active, not recruiting	NCT03226119	Phase 4
40	Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery	Active, not recruiting	NCT02853929	Phase 4
41	To Develop, Implement and Evaluate the Polio Demonstration Project Comprising of a Community Based Intervention Package for Polio Eradication in Pakistan	Active, not recruiting	NCT01908114	Phase 4
42	Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event.	Withdrawn	NCT00037115	Phase 4	interferon beta 1a;methotrexate;methylprednisolone
43	Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone	Unknown status	NCT00004645	Phase 3
44	Randomized Clinical Trial to Evaluate Immunogenicity and Safety in Mexicans Newborns	Unknown status	NCT01870206	Phase 3
45	Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)	Unknown status	NCT01343355	Phase 2, Phase 3	Tamibarotene
46	Additional 6-Month Safety Follow-up After Completion of Precursor Study 880801	Completed	NCT01604746	Phase 3
47	Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given at 6, 10, 14 Weeks and 9 Months	Completed	NCT03032419	Phase 3
48	Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine in 2, 4, 6 Months of Age	Completed	NCT03025750	Phase 3
49	Randomized Controlled Trial for Immunogenicity and Safety Evaluation of Bivalent Types 1 and 3 Oral Poliovirus Vaccine	Completed	NCT02785705	Phase 3
50	Immunogenicity and Safety of Liquid Bivalent Oral Poliomyelitis Vaccine	Completed	NCT02434770	Phase 3

Search NIH Clinical Center for Myelitis

Cochrane evidence based reviews: myelitis

Sources

Genetic Tests for Myelitis

Sources

Anatomical Context for Myelitis

MalaCards organs/tissues related to Myelitis:

⁴¹

Spinal Cord, Brain, Lung, T Cells, Bone, Bone Marrow, B Cells

Sources

Publications for Myelitis

Articles related to Myelitis:

(show top 50) (show all 1043)

#	Title	Authors	Year
1	Acute Transverse Myelitis in Children, Literature Review. ( 29696041 )	Tavasoli A....Tabrizi A.	2018
2	Enterovirus D68 and acute flaccid myelitis-evaluating the evidence for causality. ( 29482893 )	Messacar K....Dominguez S.R.	2018
3	Acute transverse myelitis following an opsoclonus-myoclonus syndrome: An unusual presentation. ( 29773357 )	Simon T....Deiva K.	2018
4	The association between acute flaccid myelitis (AFM) and Enterovirus D68 (EV-D68) - what is the evidence for causation? ( 29386095 )	Dyda A....MacIntyre C.R.	2018
5	Encephalitis and transverse myelitis in dengue and chikungunya coinfection. ( 29972580 )	Farias L.A.B.G....Pires Neto R.D.J.	2018
6	Drainage of Cerebrospinal Fluid and Blood Pressure Augmentation as Rescue Therapies for Ischemic Myelitis After Bronchial Embolization: A Case Report. ( 29851658 )	LAcpine P.A....Boisvert P.	2018
7	Short-segment transverse myelitis lesions in a cohort of Latin American patients with neuromyelitis optica spectrum disorders. ( 29789706 )	Carnero Contentti E....Caride A.	2018
8	Myelitis due to Coccidioidomycosis in an Immunocompetent Patient. ( 29808132 )	Vaysman T....Liu A.	2018
9	Systemic Lupus Erythematosus Presenting as Longitudinally Extensive Transverse Myelitis and Nephritis: A Case Report. ( 29872583 )	Zahid A.S....Talib A.	2018
10	Acute Transverse Myelitis Caused by Echovirus 11 in a Pediatric Patient: Case Report and Review of the Current Literature. ( 29372173 )	Moline H.L....Schleiss M.R.	2018
11	Acute myelitis of children with positive anti-GM1 antibody: Case series and literature review. ( 29768373 )	Wang Z....Cai X.T.	2018
12	Trident sign trumps Aquaporin-4-IgG ELISA in diagnostic value in a case of longitudinally extensive transverse myelitis. ( 29709797 )	Jolliffe E.A....Flanagan E.P.	2018
13	Two cases of sarcoidosis presenting as longitudinally extensive transverse myelitis. ( 29770929 )	Scott A.M....Kalish R.	2018
14	Autoimmune myelitis in a CLL patient undergoing treatment with ibrutinib. ( 29804266 )	Wanner D....Steurer M.	2018
15	Neurosyphilis as a Cause of Transverse Myelitis in a Teenage Girl. ( 29602529 )	Jo Yaphockun K.K....Wai S.	2018
16	Long-term outcomes of varicella zoster virus infection-related myelitis in 10 immunocompetent patients. ( 29957386 )	Wang X....Yu S.	2018
17	Evaluation of idiopathic transverse myelitis revealing specific myelopathy diagnoses. ( 29247071 )	Zalewski N.L....Keegan B.M.	2018
18	Paraneoplastic striatal encephalitis and myelitis associated with anti-CV2/CRMP-5 antibodies in a patient with small cell lung cancer. ( 29777943 )	Dericioglu N....Tan E.	2018
19	Frequency of Aquaporin-4 Immunoglobulin G in Longitudinally Extensive Transverse Myelitis With Antiphospholipid Antibodies. ( 29655487 )	Guerra H....Flanagan E.P.	2018
20	Clinical features and prognoses of acute transverse myelitis in patients with systemic lupus erythematosus. ( 29294596 )	Ahn S.M....Yoo B.	2018
21	Radiation-Induced Myelitis: Initial and Follow-Up MRI and Clinical Features in Patients at a Single Tertiary Care Institution during 20 Years. ( 29773568 )	Khan M....Izbudak I.	2018
22	To start immune therapy or not? An unusual presentation of longitudinally extensive transverse myelitis with pyrexia. ( 29725838 )	Rounis E....Sen A.	2018
23	Necrotic-hemorrhagic myelitis: A rare malignant variant of parainfectious acute disseminated encephalomyelitis in childhood. ( 29249379 )	Preziosa P....Filippi M.	2018
24	MOG-antibody demyelinating diseases: a case of post-partum severe rhombencephalitis and transverse myelitis. ( 29438836 )	Vecchio D....Cantello R.	2018
25	Myelitis and Polyradiculoneuropathy With Severe Pain: Unusual Neurological Manifestations as Presenting Symptoms of Brucellosis. ( 29953037 )	Marques I.B....Gil-Gouveia R.	2018
26	Guillain-BarrAc syndrome, transverse myelitis and infectious diseases. ( 29375121 )	RodrA-guez Y....Anaya J.M.	2018
27	Short transverse myelitis in Chinese patients with neuromyelitis optica spectrum disorders. ( 29499441 )	Hu H....Ye J.	2018
28	Hypereosinophilic atopic transverse myelitis. ( 29888734 )	Fasola F.A....Aworanti O.W.	2018
29	Familial monophasic acute transverse myelitis due to the pathogenic variant in <i>VPS37A</i>. ( 29473047 )	Mealy M.A....Levy M.	2018
30	Possible Combined Central and Peripheral Demyelination Presenting as Optic Neuritis, Cervical Myelitis, and Demyelinating Polyneuropathy with Marked Nerve Hypertrophy. ( 29540658 )	Tajima Y....Mito Y.	2018
31	Natural history of longitudinally extensive transverse myelitis in 35 Hispanic patients with systemic lupus erythematosus: good short-term functional outcome and paradoxical increase in long-term mortality. ( 29635997 )	Flores-Silva F.D....ValdAcs-Ferrer S.I.	2018
32	Longitudinally extensive transverse myelitis following dengue virus infection: A rare entity. ( 29536963 )	Malik S....Punj A.	2018
33	CLIPPERS with longitudinally extensive transverse myelitis: Role of T versus B cells. ( 29406923 )	Olmes D.G....Linker R.A.	2018
34	Novel Glial Targets and Recurrent Longitudinally Extensive Transverse Myelitis. ( 29710213 )	Jitprapaikulsan J....Pittock S.J.	2018
35	MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder. ( 29670575 )	Dos Passos G.R....Sato D.K.	2018
36	Cytomegalovirus associated longitudinally extensive transverse myelitis and acute hepatitis in an immunocompetent adult. ( 29396069 )	Hooi W.F....Pollard J.	2018
37	MRI Features of Aquaporin-4 Antibody-Positive Longitudinally Extensive Transverse Myelitis: Insights into the Diagnosis of Neuromyelitis Optica Spectrum Disorders. ( 29449281 )	Chee C.G....Kang H.S.	2018
38	Clinical Features of Acute Flaccid Myelitis Temporally Associated With an Enterovirus D68 Outbreak: Results of a Nationwide Survey of Acute Flaccid Paralysis in Japan, August-December 2015. ( 29028962 )	Chong P.F....Tanaka-Taya K.	2018
39	Toxic Myelitis and Arachnoiditis After Intrathecal Delivery of Bupivacaine via an Implanted Drug Delivery System: Case Report and Review of the Literature. ( 29719742 )	Huang M....Simpson R.K.	2018
40	Reversible paraspinal muscle hyperintensity in anti-MOG antibody-associated transverse myelitis. ( 29114566 )	Pandit L....Kaneko K.	2018
41	Effects of electroacupuncture on bladder and bowel function in patients with transverse myelitis: a prospective observational study. ( 29909400 )	Wu J....Liu Z.	2018
42	Longitudinally Extensive Transverse Myelitis. ( 29862450 )	Chawla D....Juneja M.	2018
43	Acute myelitis associated with human herpesvirus 7 infection. ( 29359421 )	Fukuhara T....Shimojo N.	2018
44	Longitudinally extensive transverse myelitis with pulmonary tuberculosis: Two case reports. ( 29505015 )	Zhang Y....Deng H.	2018
45	Acute transverse myelitis following scrub typhus: A case report and review of the literature. ( 29350608 )	Ryu H.S....Lee J.K.	2018
46	Causation of Acute Flaccid Paralysis by Myelitis and Myositis in Enterovirus-D68 Infected Mice Deficient in Interferon I+I^/I^ Receptor Deficient Mice. ( 29329211 )	Morrey J.D....Tarbet E.B.	2018
47	Enterovirus D68-Associated Acute Flaccid Myelitis in Immunocompromised Woman, Italy. ( 28930024 )	Giombini E....Valli M.B.	2017
48	Acute motor axonal neuropathy and transverse myelitis overlap: the importance of history taking. ( 29143293 )	Degan D....Notturno F.	2017
49	Cytomegalovirus-related transverse myelitis in an immunocompetent host: a subacute onset of an immune-mediated disease? ( 28801328 )	Merchan-Del Hierro X....Halalau A.	2017
50	Acute transverse myelitis in a pediatric patient. ( 28215959 )	Donovan M....DePiero A.	2017

Sources

Genes for Myelitis

Genes related to Myelitis (0 elite genes):

(show all 11)

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence	PubmedIds
1	AQP4	Aquaporin 4	Protein Coding	37.11	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : Publications (show sections)	19348177 19140826 18509235 (more) 19917985
2	MBP	Myelin Basic Protein	Protein Coding	21.72	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁵ GeneCards inferred via : DISEASES inferred (show sections)	11086392 9436377
3	IL6	Interleukin 6	Protein Coding	21.38	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
4	HLA-DPB1	Major Histocompatibility Complex, Class II, DP Beta 1	Protein Coding	21.14	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
5	APOH	Apolipoprotein H	Protein Coding	20.74	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
6	IL9	Interleukin 9	Protein Coding	20.34	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
7	IL17A	Interleukin 17A	Protein Coding	20.05	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
8	TNF	Tumor Necrosis Factor	Protein Coding	19.83	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
9	MOG	Myelin Oligodendrocyte Glycoprotein	Protein Coding	17.87	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
10	CCL11	C-C Motif Chemokine Ligand 11	Protein Coding	16.97	GeneCards inferred via : Publications (show sections)
11	ITGB3	Integrin Subunit Beta 3	Protein Coding	16.62	GeneCards inferred via : Publications (show sections)

Sources

Variations for Myelitis

Sources

Expression for Myelitis

Search GEO for disease gene expression data for Myelitis.

Sources

Pathways for Myelitis

Pathways related to Myelitis according to GeneCards Suite gene sharing:

(show all 28)

#	Super pathways	Score	Top Affiliating Genes
1	TGF-Beta Pathway ⁶⁴ Show member pathways JAK-STAT Pathway ⁶⁴ JNK Pathway ⁶⁴ MAPK Family Pathway ⁶⁴ Regulation of eIF4 and p70S6K ⁶⁴ SOCS Pathway ⁶⁴	13.26	CCL11 IL17A IL6 IL9 ITGB3 TNF
2	Akt Signaling ⁶⁴ Show member pathways p38 Signaling ⁶⁴ Tec Kinases Signaling ⁶⁴	13.16	CCL11 IL17A IL6 IL9 ITGB3 TNF
3	PAK Pathway ⁶⁴ Show member pathways Antioxidant Action of Vitamin-C ⁶⁴ Epithelial Adherens Junctions ⁶⁴	13.09	CCL11 IL17A IL6 IL9 TNF
4	Cytokine Signaling in Immune system ⁶⁶ Show member pathways Signaling by Interleukins ⁶⁶	13.06	CCL11 HLA-DPB1 IL17A IL6 IL9 ITGB3
5	Common Cytokine Receptor Gamma-Chain Family Signaling Pathways ⁶⁵ Show member pathways Adipokines and Insulin Signaling Pathways ⁶⁵ Development Thrombopoietin-regulated cell processes ²² IL-15 Signaling Pathways ⁶⁵ IL-2 Signaling Pathways ⁶⁵ IL-21 Signaling Pathways ⁶⁵ IL-4 Signaling Pathway ¹ IL-4 Signaling Pathways ⁶⁵ IL-7 Signaling Pathways ⁶⁵ IL-9 Pathway ⁶⁴ IL-9 Signaling Pathways ⁶⁵ Immune response IL-4 signaling pathway ²² Immune response IL-9 signaling pathway ²²	12.71	CCL11 IL6 IL9 TNF
6	Allograft rejection ¹ ³⁷ Show member pathways Antigen processing and presentation ³⁷ Asthma ³⁷ Autoimmune thyroid disease ³⁷ CTL Mediated Apoptosis ⁶⁴ Graft-versus-host disease ³⁷ Intestinal immune network for IgA production ³⁷ THC Differentiation Pathway ⁶⁴ Type I diabetes mellitus ³⁷ Viral myocarditis ³⁷	12.47	CCL11 HLA-DPB1 IL17A IL6 IL9 TNF
7	Regulation of IFNA signaling ⁶⁶ Show member pathways Cytokine Network ⁶⁴ Immune response IFN alpha/beta signaling pathway ²² Interferon alpha/beta signaling ⁶⁶ Interleukin-19, 20, 22, 24 ⁶⁶ Jak/STAT Signaling Pathway ⁶⁵ Jak-STAT signaling pathway ³⁷	12.42	IL17A IL6 IL9 TNF
8	Th17 cell differentiation ³⁷ Show member pathways Inflammatory bowel disease (IBD) ³⁷ Th1 and Th2 cell differentiation ³⁷	12.22	HLA-DPB1 IL17A IL6 TNF
9	T cell receptor signaling pathway ³⁷ Show member pathways T-Cell antigen Receptor (TCR) Signaling Pathway ¹ T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection ¹	12.19	IL17A IL6 IL9 TNF
10	Th1 Differentiation Pathway ⁶⁵ Show member pathways IL27-mediated signaling events ¹ IL-6-type cytokine receptor ligand interactions ⁶⁶ Interleukin-6 family signaling ⁶⁶ Interleukin-6 signaling ⁶⁶ Th17 Differentiation Pathway ⁶⁵	12.07	IL17A IL6 TNF
11	IL-17 Family Signaling Pathways ⁶⁵ Show member pathways IL17 signaling pathway ¹ IL-17 signaling pathway ³⁷ Interleukin-17 signaling ⁶⁶ Mucin expression in CF via IL-6, IL-17 signaling pathways ²²	12.07	CCL11 IL17A IL6 TNF
12	Tuberculosis ³⁷	12.04	HLA-DPB1 IL6 TNF
13	Dilated cardiomyopathy (DCM) ³⁷ Show member pathways Hypertrophic cardiomyopathy (HCM) ³⁷	12.02	IL6 ITGB3 TNF
14	Bacterial infections in CF airways ²² Show member pathways IL-1 beta-dependent CFTR expression ²² Immune response Bacterial infections in normal airways ²² Immune response TLR signaling pathways ²²	11.99	CCL11 IL6 TNF
15	Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways ¹	11.98	AQP4 IL6 TNF
16	Immune response IFN gamma signaling pathway ²² Show member pathways IFN-gamma pathway ¹	11.88	CCL11 IL17A IL6 IL9
17	Hematopoietic Stem Cell Differentiation Pathways and Lineage-specific Markers ⁶⁵	11.8	IL6 ITGB3 TNF
18	Spinal Cord Injury ¹	11.75	AQP4 IL6 MBP TNF
19	Interleukin-4 and 13 signaling ⁶⁶	11.68	CCL11 IL17A IL6 TNF
20	Innate Lymphoid Cell Differentiation Pathways ⁶⁵	11.59	IL17A IL9 TNF
21	Hematopoietic cell lineage ³⁷	11.44	HLA-DPB1 IL6 ITGB3 TNF
22	Lung fibrosis ¹	11.43	CCL11 IL6 TNF
23	Rheumatoid arthritis ³⁷	11.21	HLA-DPB1 IL17A IL6 TNF
24	Antifolate resistance ³⁷	11.12	IL6 TNF
25	Cytokines and Inflammatory Response ¹	11.1	IL6 TNF
26	Transcription factor regulation in adipogenesis ¹	10.93	IL6 TNF
27	Overview of nanoparticle effects ¹	10.85	IL6 TNF
28	Development and heterogeneity of the ILC family ¹	10.43	IL17A IL6 IL9 TNF

Sources

GO Terms for Myelitis

Cellular components related to Myelitis according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	extracellular space	GO:0005615	9.43	APOH CCL11 IL17A IL6 IL9 TNF
2	external side of plasma membrane	GO:0009897	8.92	AQP4 IL17A MOG TNF

Biological processes related to Myelitis according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	regulation of signaling receptor activity	GO:0010469	9.65	CCL11 IL17A IL6 IL9 TNF
2	cytokine-mediated signaling pathway	GO:0019221	9.62	CCL11 IL17A IL6 TNF
3	inflammatory response	GO:0006954	9.55	CCL11 IL17A IL6 IL9 TNF
4	positive regulation of interleukin-6 secretion	GO:2000778	9.43	IL17A MBP
5	positive regulation of osteoclast differentiation	GO:0045672	9.4	IL17A TNF
6	positive regulation of chemokine production	GO:0032722	9.37	IL6 TNF
7	immune response	GO:0006955	9.17	CCL11 HLA-DPB1 IL17A IL6 IL9 MBP
8	negative regulation of lipid storage	GO:0010888	9.13	IL6 ITGB3 TNF

Molecular functions related to Myelitis according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	protease binding	GO:0002020	9.13	ITGB3 MBP TNF
2	cytokine activity	GO:0005125	9.02	CCL11 IL17A IL6 IL9 TNF

Sources

Sources for Myelitis

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ ExPASy

¹⁸ FDA Approved Drugs

¹⁹ FMA

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ Genetics Home Reference

²⁶ GenomeRNAi

²⁷ GEO DataSets

²⁸ GO

²⁹ GTR

³⁰ HGMD

³¹ HMDB

³² HPO

³³ ICD10

³⁴ ICD10 via Orphanet

³⁵ ICD9CM

³⁶ IUPHAR

³⁷ KEGG

³⁸ LifeMap

³⁹ LncRNADisease

⁴⁰ LOVD

⁴¹ MalaCards

⁴² MedGen

⁴³ MedlinePlus

⁴⁴ MeSH

⁴⁵ MESH via Orphanet

⁴⁶ MGI

⁴⁷ miR2Disease

⁴⁸ NCBI Bookshelf

⁴⁹ NCI

⁵⁰ NCIt

⁵¹ NDF-RT

⁵² NIH Clinical Center

⁵³ NIH Rare Diseases

⁵⁴ NINDS

⁵⁵ Novoseek

⁵⁶ Novus Biologicals

⁵⁷ OMIM

⁵⁸ OMIM via Orphanet

⁵⁹ Orphanet

⁶⁰ PathCards

⁶¹ PharmGKB

⁶² PubMed

⁶³ PubMed Health

⁶⁴ QIAGEN

⁶⁵ R&D Systems

⁶⁶ Reactome

⁶⁷ Sino Biological

⁶⁸ SNOMED-CT

⁶⁹ SNOMED-CT via HPO

⁷⁰ SNOMED-CT via Orphanet

⁷¹ TGDB

⁷² Tocris

⁷³ UMLS

⁷⁴ UMLS via Orphanet

⁷⁵ UniProtKB/Swiss-Prot

⁷⁶ Wikipedia